The store will not work correctly when cookies are disabled.
9-(4-chlorophenethyl)-6-[(4-chlorophenethyl)thio]-9H-purine
ID: ALA4764259
PubChem CID: 162662026
Max Phase: Preclinical
Molecular Formula: C20H16Cl2N4S
Molecular Weight: 415.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccc(CCSc2ncnc3c2ncn3Cc2ccc(Cl)cc2)cc1
Standard InChI: InChI=1S/C20H16Cl2N4S/c21-16-5-1-14(2-6-16)9-10-27-20-18-19(23-12-24-20)26(13-25-18)11-15-3-7-17(22)8-4-15/h1-8,12-13H,9-11H2
Standard InChI Key: PZBLXMMPOKTMGE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
12.2895 -18.7417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2883 -19.5612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9964 -19.9702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9946 -18.3328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7032 -18.7381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7080 -19.5567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4880 -19.8052 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9654 -19.1400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4803 -18.4807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9921 -17.5157 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.2832 -17.1092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5767 -17.5199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8678 -17.1134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8689 -16.2970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1608 -15.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4534 -16.3014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4585 -17.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1671 -17.5255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7439 -15.8959 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.7451 -20.5809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5454 -20.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7972 -21.5219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5967 -21.6873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1408 -21.0765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8800 -20.2976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0811 -20.1359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9414 -21.2407 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
7 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 415.35 | Molecular Weight (Monoisotopic): 414.0473 | AlogP: 5.52 | #Rotatable Bonds: 6 |
Polar Surface Area: 43.60 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 3.05 | CX LogP: 5.99 | CX LogD: 5.99 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.31 | Np Likeness Score: -1.35 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |